Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

INTRODUCTION: Given the relatively small number of patients with haemophilia A, head-to-head comparisons between recombinant FVIII (rFVIII) products are difficult to conduct. This study compared the efficacy and consumption of rVIII-SingleChain (lonoctocog alfa, AFSTYLA(®)) with rAHF-PFM (octocog al...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanad, Santiago, Núñez, Ramiro, Poveda, Jose Luis, Kurnik, Karin, Goldmann, Georg, Andreozzi, Valeska, Vandewalle, Björn, Santos, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408075/
https://www.ncbi.nlm.nih.gov/pubmed/34368918
http://dx.doi.org/10.1007/s12325-021-01853-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408075/
https://www.ncbi.nlm.nih.gov/pubmed/34368918
http://dx.doi.org/10.1007/s12325-021-01853-0

Ejemplares similares